Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CardioBridge's foldable heart pump may change paradigm for cardiac support

This article was originally published in Clinica

Executive Summary

German company CardioBridge is making progress with a first-in-man trial of what it claims could become the most powerful heart pump capable of being implanted in a "truly" minimally invasive fashion. The device is called the Reitan Catheter Pump (RCP). It has been developed to fill the gap that exists between what the firm describes as the "less effective" percutaneous intra-aortic balloon pumps (IABPs) and the "expensive and invasive" left ventricular assist devices (LVADs), which are implanted surgically. It is intended to provide short-term circulatory support throughout periods of impaired left or right ventricular function.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048993

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel